From February 2, 2024 to February 8, 2024, the company has repurchased 4,543,000 shares, representing 1.18% for CNY 55 million. With this, the company has completed the repurchase of 4,543,000 shares, representing 1.18% for CNY 55 million under the buyback announced on February 2, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.66 CNY | +1.49% | -6.34% | -6.00% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.00% | 820M | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B |
- Stock Market
- Equities
- 300233 Stock
- News Shandong Jincheng Pharmaceutical Group Co., Ltd
- Tranche Update on Shandong Jincheng Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on February 2, 2024.